IRIS
MURDACA, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.728
AS - Asia 2.170
NA - Nord America 1.236
SA - Sud America 203
AF - Africa 27
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.368
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 17.344
US - Stati Uniti d'America 1.169
SG - Singapore 880
CN - Cina 594
VN - Vietnam 379
FR - Francia 165
BR - Brasile 123
HK - Hong Kong 90
BD - Bangladesh 71
FI - Finlandia 68
DE - Germania 43
AR - Argentina 39
MX - Messico 30
GB - Regno Unito 29
JP - Giappone 24
IQ - Iraq 22
IN - India 21
CA - Canada 16
ID - Indonesia 16
NL - Olanda 11
RU - Federazione Russa 11
ZA - Sudafrica 11
IE - Irlanda 10
PH - Filippine 9
CH - Svizzera 8
TR - Turchia 8
CO - Colombia 7
EC - Ecuador 7
ES - Italia 7
MA - Marocco 7
PK - Pakistan 7
PY - Paraguay 7
TH - Thailandia 7
CL - Cile 6
JO - Giordania 6
PL - Polonia 6
VE - Venezuela 6
CR - Costa Rica 5
TW - Taiwan 5
UZ - Uzbekistan 5
MY - Malesia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AU - Australia 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
PE - Perù 3
UA - Ucraina 3
UY - Uruguay 3
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
MD - Moldavia 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
SE - Svezia 2
AM - Armenia 1
AT - Austria 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CY - Cipro 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
KE - Kenya 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MT - Malta 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.368
Salva come PNG Salva come JPEG
Città #
Genova 9.464
Genoa 5.061
Rapallo 1.398
Vado Ligure 1.249
Singapore 417
San Jose 371
Lauterbourg 155
Ashburn 115
Beijing 115
Ho Chi Minh City 105
Hanoi 94
Hong Kong 84
Council Bluffs 76
New York 69
Helsinki 66
Bordighera 47
Santa Clara 38
Frankfurt am Main 33
Los Angeles 26
Mexico City 21
Buffalo 20
Haiphong 19
Milan 19
Tokyo 19
Orem 18
Tianjin 14
Chicago 12
Phoenix 11
St Louis 11
Dublin 10
Baghdad 9
Biên Hòa 9
Da Nang 9
São Paulo 9
Amsterdam 8
Zurich 8
London 7
Shanghai 7
Amman 6
Bắc Ninh 6
Charlotte 6
Chennai 6
City of London 6
Johannesburg 6
Poplar 6
Quảng Ngãi 6
Rio de Janeiro 6
Rome 6
Warsaw 6
Atlanta 5
Boston 5
Cardiff 5
Dallas 5
Des Moines 5
Madrid 5
Montreal 5
Quận Ba 5
Tashkent 5
Acalanes Ridge 4
Catania 4
Dhaka 4
Florence 4
Guangzhou 4
Kuala Lumpur 4
Naples 4
Paris 4
San José 4
Seattle 4
Asunción 3
Baku 3
Bangkok 3
Belo Horizonte 3
Cape Town 3
Chester 3
Columbus 3
Curitiba 3
Las Vegas 3
Memphis 3
Miano 3
Montevideo 3
Quito 3
Salvador 3
San Francisco 3
Santo Domingo 3
Sarnthein 3
Thái Bình 3
Thái Nguyên 3
Turin 3
Vũng Tàu 3
Addis Ababa 2
Aurora 2
Bari 2
Barletta 2
Boardman 2
Bologna 2
Brasília 2
Buenos Aires 2
Burzaco 2
Bình Dương 2
Campos dos Goytacazes 2
Totale 19.459
Salva come PNG Salva come JPEG
Nome #
Non-antigen-specific CD8(+) T suppressor lymphocytes in diseases characterized by chronic immune responses and inflammation. 269
Infection risk associated with anti-TNF-α agents: A review 237
A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer 228
Beneficial effects of long-term treatment with bosentan on the development of pulmonary arterial hypertension in patients with systemic sclerosis 225
Autoimmune intrahepatic cholangiopathy associated with antiphospholipid antibody syndrome 207
Autoimmune central diabetes insipidus in a patient with ureaplasma urealyticum infection and review on new triggers of immune response. 207
Characteristics of current heart failure patients admitted to internal medicine vs. cardiology hospital units: the VASCO study 206
ACUTE CARDIAC FAILURE AND IGA NEPHROPATHY: AN UNCOMMON SLE ONSET 200
Vaccine-preventable infections in Systemic Lupus Erythematosus 199
Allergen-driven HLA-G expression and secretion in peripheral blood mononuclear cells from allergic rhinitis patients 196
Immunogenicity of infliximab and adalimumab: What is its role in hypersensitivity and modulation of therapeutic efficacy and safety? 196
TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis 193
Adalimumab for the treatment of immune-mediated diseases: an update on old and recent indications 192
Adult iatrogenic Cushing's syndrome induced by topical skin corticosteroid misuse 187
The antiphospholipid syndrome: from pathophysiology to treatment 185
Behavior of soluble HLA-A, -B, -C and HLA-G molecules in patients with chronic hepatitis C virus infection undergoing pegylated interferon-α and ribavirin treatment: potential role as markers of response to antiviral therapy 181
Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans 179
Treatment Algorithms for Systemic Sclerosis According to Experts 177
Update upon efficacy and safety of etanercept for the treatment of spondyloarthritis and juvenile idiopathic arthritis 175
Impact of pharmacogenomics upon the therapeutic response to etanercept in psoriasis and psoriatic arthritis 174
Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis 173
Immunoregulatory Role of HLA-G in Allergic Diseases 172
General surgery, translational lymphology and lymphatic surgery 172
Current recommendation to reduce the burden of bacterial and viral infections in patients affected by systemic lupus erythematosus 171
Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome 171
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 171
Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events 167
Pharmacogenetics of etanercept: role of TNF-α gene polymorphisms in improving its efficacy 167
A rare hepatic mass in an Italian resident 167
Soluble HLA-G molecule in patients with perennial allergic rhinitis. 166
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 166
Body mass index in Th1 and Th2 diseases. 164
Monkeypox 2024 outbreak: Fifty essential questions and answers 163
Adipokines and sublingual immunotherapy: preliminary report. 162
Anti-tumour necrosis factor-a treatment with infliximab for disseminated granuloma annulare 159
An Uncommon Presentation of Pancreatic Carcinoma 159
Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens. 158
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 158
Apoptosis in the Homeostasis of the Immune System and in Human Immune Mediated Diseases 154
Serum vascular endothelial growth factor and sublingual immunotherapy 152
Update upon the infection risk in patients receiving TNF alpha inhibitors 152
Genetic factors and systemic sclerosis 152
Effects of antagomiRs on different lung diseases in human, cellular, and animal models 152
Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine versus standard-dose intramuscular vaccine in HIV-1-infected adults. 151
A case of transposition of the great arteries in a female infant of a HIV-1 infected woman. Potential teratogenic effect of antiretroviral drugs. 151
Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution. 150
HLA-G expression in gastric carcinoma: clinicopathological correlations and prognostic impact 148
Endothelial dysfunction in rheumatic autoimmune diseases. 148
Use of leflunomide plus TNF-α inhibitors in rheumatoid arthritis 147
Hypoadiponectinemia in lipodystrophic HIV individuals: a metabolic marker of subclinical cardiac damage 146
Detection of influenza A(H1N1)pdm09 virus in a patient travelling from Shanghai to Italy in July 2018: An uncommon clinical presentation in a non-seasonal period 146
Plicometer skin test: a new technique for the evaluation of cutaneous involvement in systemic sclerosis. 145
Potential use of TNF-α inhibitors in systemic sclerosis. 144
Significant NK cell activation associated with decreased cytolytic function in peripheral blood of HIV-1 infected patients 143
Interleukin-2 therapy in patients with HIV infection 143
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system’s inhibitor denosumab vs. bisphosphonates 142
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence 141
Two year sublingual immunotherapy affects serum leptin 141
Anti-TNF-alpha inhibitors: a new therapeutic approach for inflammatory immune-mediated diseases: an update upon efficacy and adverse events. 141
Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus 141
Lymphatic microsurgery to treat lymphedema: techniques and indications for better results. 140
Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. 140
Low expression of inhibitory natural killer receptors in CD8 cytotoxic T lymphocytes in long-term non-progressor HIV-1-infected patients 140
Serum adiponectin levels in patients with pollen-induced allergic rhinitis 139
Serum interleukin-17 levels are related to clinical severity in allergic rhinitis 139
Remission of Brucella endocarditis in a patient with mitral valve mechanical prosthesis by antibiotic therapy alone: a case report 139
Current views on diagnostic approach and treatment of lymphedema 139
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study 139
Postexposure HIV prophylaxis regimen. 138
Effects of TNF-α inhibitors upon the mechanisms of action of VEGF. 137
Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch 137
Immunogenicity of infliximab and adalimumab 137
Drug-induced aminotransferase alterations during antiretroviral HIV post-exposure prophylaxis 136
Determination of lymphotoxin-α levels in patients with psoriatic arthritis undergoing etanercept treatment 136
Il-33/il-31 axis in immune-mediated and allergic diseases 134
Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis. 133
Accelerated atherosclerosis in patients with Systemic Lupus Erythematosus. 133
Antiphospholipid syndrome and reversible posterior leukoencephalopathy syndrome. 132
Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications 132
The role of Th17 lymphocytes in the autoimmune and chronic inflammatory diseases 130
Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: Current views upon safety and immunogenicity. 130
Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis 130
Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current evidences upon safety and immunogenicity 130
Hepatic safety and postexposure prophylaxis 130
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 129
Pharmacogenetics and future therapeutic scenarios: what affects the prediction of response to treatment with etanercept? 129
Soluble HLA-G serum levels in patients with the Acquired Immunodeficiency Syndrome affected by different AIDS-defining conditions before and after anti-retroviral treatment 127
Selective TNF-α inhibitor-induced injection site reactions. 126
Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety. 126
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study 126
A compilation answering 50 questions on Monkeypox virus and the current Monkeypox outbreak 125
HLA-G Expressing Immune Cells in Immune Mediated Diseases 124
Expression of membrane-bound human leucocyte antigen-G in systemic sclerosis and systemic lupus erythematosus 124
Efficacy and safety of etanercept in chronic immune-mediated disease. 122
Recurrent intestinal perforation associated with thrombosis of inferior vena cava: uncommon presentation of antiphospholipid syndrome. 121
Emerging biologic drugs for the treatment of rheumatoid arthritis 119
Differential diagnosis in recurrent intestinal perforation: chronic inflammatory disease with intestinal lymphedema or antiphospholipid syndrome? 119
Update upon efficacy and safety of TNF-α inhibitors. 119
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study 118
Differential disappearance of inhibitory natural killer cell receptors during HAART and possible impairment of HIV-1-specific CD8 cytotoxic T lymphocytes. 117
Totale 15.450
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.751
article - articoli 73.751
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.502
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021188 0 0 0 0 0 0 0 0 0 0 95 93
2021/20221.701 43 116 123 190 56 126 78 406 101 154 70 238
2022/20231.671 143 105 28 163 298 285 10 145 261 15 185 33
2023/20241.007 39 149 19 133 66 149 95 80 54 15 63 145
2024/20253.280 111 219 110 236 418 309 363 522 120 152 329 391
2025/20266.134 689 261 565 650 744 535 967 261 430 565 467 0
Totale 21.844